Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7642)
All Articles published online
|
Publishing Process of This Article
|
Jan 28, 2017 (publication date) through Dec 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ballester-Ferré MP, Martínez F, Garcia-Gimeno N, Mora F, Serra MA. Miliary tuberculosis infection during hepatitis C treatment with sofosbuvir and ledipasvir plus ribavirin. World J Hepatol 2017; 9(3): 161-166 [PMID: 28217253 DOI: 10.4254/wjh.v9.i3.161] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v9/i3/161.htm |
| Number | Citing Articles |
| 1 |
Sreekumar Othumpangat, John D. Noti. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions. Side Effects of Drugs Annual 2018; 40: 345 doi: 10.1016/bs.seda.2018.08.005
|
| 2 |
Marc Pedrosa, Sara Nogales, Mercedes Vergara, Mireia Miquel, Meritxell Casas, Blai Dalmau, Bernat Font, Jordi Sánchez-Delgado. Reactivation of peritoneal and pleural tuberculosis during hepatitis C treatment with direct-acting antivirals. Gastroenterología y Hepatología (English Edition) 2019; 42(3): 174 doi: 10.1016/j.gastre.2019.02.019
|
| 3 |
Claudia Colomba, Laura Saporito, Paola Di Carlo, Manlio Tolomeo, Adriana Cervo, Alberto Firenze, Marcello Trizzino, Antonio Cascio. Direct-acting antivirals and visceral leishmaniasis: a case report. BMC Infectious Diseases 2019; 19(1) doi: 10.1186/s12879-019-3947-x
|
| 4 |
N. A. Stogova. Bilateral pleural effusion: etiology, diagnostics. PULMONOLOGIYA 2022; 32(6): 885 doi: 10.18093/0869-0189-2022-32-6-885-890
|
| 5 |
Braira Wahid. Hepatotoxicity and virological breakthrough of HCV following treatment with sofosbuvir, daclatasvir, and ribavirin in patients previously treated for tuberculosis. Journal of Medical Virology 2019; 91(12): 2195 doi: 10.1002/jmv.25557
|
| 6 |
Takashi Kida, Atsushi Umemura, Shunya Kaneshita, Risa Sagawa, Takuya Inoue, Shogo Toyama, Makoto Wada, Masataka Kohno, Ryo Oda, Tohru Inaba, Yoshito Itoh, Yutaka Kawahito. Effectiveness and safety of chronic hepatitis C treatment with direct-acting antivirals in patients with rheumatic diseases: A case-series. Modern Rheumatology 2020; 30(6): 1009 doi: 10.1080/14397595.2019.1682787
|
| 7 |
Marc Pedrosa, Sara Nogales, Mercedes Vergara, Mireia Miquel, Meritxell Casas, Blai Dalmau, Bernat Font, Jordi Sánchez-Delgado. Reactivación de tuberculosis peritoneal y pleural durante el tratamiento de la hepatitis C con antivirales de acción directa. Gastroenterología y Hepatología 2019; 42(3): 174 doi: 10.1016/j.gastrohep.2018.03.003
|